0001209191-19-010167.txt : 20190214 0001209191-19-010167.hdr.sgml : 20190214 20190214163007 ACCESSION NUMBER: 0001209191-19-010167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190212 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALABRO JOSEPH M CENTRAL INDEX KEY: 0001218834 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 19607013 MAIL ADDRESS: STREET 1: C/O PEDIATRIX MEDICAL GROUP-LEGAL DEPT., STREET 2: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-12 0 0000893949 MEDNAX, INC. MD 0001218834 CALABRO JOSEPH M 1301 CONCORD TERRACE SUNRISE FL 33323 0 1 0 0 President `Common Stock 2019-02-12 4 A 0 108791 0.00 A 441538 D Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 27,198 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022. /s/ Dominic J. Andreano, Attorney-in-Fact 2019-02-14